CN102861197A - Traditional Chinese medicine composition for treating injuries from falls, fractures, contusions and strains - Google Patents
Traditional Chinese medicine composition for treating injuries from falls, fractures, contusions and strains Download PDFInfo
- Publication number
- CN102861197A CN102861197A CN2012104080237A CN201210408023A CN102861197A CN 102861197 A CN102861197 A CN 102861197A CN 2012104080237 A CN2012104080237 A CN 2012104080237A CN 201210408023 A CN201210408023 A CN 201210408023A CN 102861197 A CN102861197 A CN 102861197A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- traditional chinese
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating injuries from falls, fractures, contusions and strains and belongs to a traditional Chinese medicine composition. The traditional Chinese medicine composition is composed of Chinese angelica, red flowers, snakegourd roots, bupleurum, pangolin scales, peach kernels, frankincense, myrrh, dragon's blood and liquorice roots according to a certain weight proportion. The traditional Chinese medicine composition is capable of promoting circulation, removing stasis, relaxing muscles, dredging collaterals, stopping bleeding, promoting tissue regeneration, reducing swelling, relieving pains and effectively treating the injuries from the falls, the fractures, the contusions and the strains.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, be specifically related to a kind of Chinese medicine composition for the treatment of traumatic injury.
Background technology
Traumatic injury mainly refers to pounce on, impact etc. because falling the soft tissue injury that causes, wound swelling pain etc.Its main pathology is for standing direct wound, and perhaps microcirculation disturbance has appearred in indirectly wound and for a long time tissue of strain.Because capillary wall sepage or hemorrhage has caused the formation of the hypostasis thing of tissue, and aseptic inflammation has occured, and causes swollen tissue pain.If can not impel the absorption of hypostasis thing, will produce adhesion.The adhesion meeting generation ischemic contracture of muscle, tendon, the outer adhesion congestion of intraarticular are stopped up and are stagnated, and therefore the blood resistance of holding one's breath is take pain, swelling as main manifestations.Mostly occur in the joint and periarticular tissue, the lighter injures skin, more than in a short time recovery from illness.Severe one is injured in the sinews or bones, and stadium is longer, has a strong impact on quality of life.At present the medicine of this type of traumatic injury for the treatment of is a lot, mostly is greatly in the affected part and applies plaster, smears medicated wine and maybe will verify and be applied to sore spot after Chinese herbal medicine is smashed to pieces, exists pain relieving slow, subsides a swelling not obvious the dissatisfactory defective of therapeutic effect.Western medical treatment bothers very much, and curative effect is very slow, needs antiinflammatory to control
Treat, treatment cycle is long, the many suffers of patient are tormented, and medical expense is high.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition, this Chinese medicine composition has evident in efficacy for the treatment traumatic injury, and curative effect is fast, short treating period, and cost is low, characteristics simple to operate.
The present invention selects Radix Angelicae Sinensis, Flos Carthami, Radix Trichosanthis, Radix Bupleuri, Squama Manis, Semen Persicae, Olibanum, Myrrha, Sanguis Draxonis and Radix Glycyrrhizae to make up, with these drug regimens so that each efficacy of drugs produces synergism, make it to have blood circulation promoting and blood stasis dispelling, channels sootheing and network vessel quickening, hemostasia and promoting granulation, the effect of reducing swelling and alleviating pain, thus traumatic injury can effectively be treated.
The effect of Chinese medicine of the present invention:
Wherein: Radix Angelicae Sinensis: the root of umbelliferae angelica.Warm in nature, sweet in the mouth, suffering.Return liver, the heart, spleen channel.The effect that having enriches blood invigorates blood circulation.Be used for injury from falling down.
Flos Carthami: be the tubular corolla of feverfew Flos Carthami.Warm in nature, acrid in the mouth.GUIXIN, Liver Channel.Has promoting blood circulation to restore menstrual flow, the effect of stasis-dispelling and pain-killing.Be used for injury from falling down.
Radix Trichosanthis: be the dry root of cucurbitaceous plant Fructus Trichosanthis or trichosanthes rosthornii Harms.Cold nature, mildly bitter flavor, sweet.Attach to the lung and stomach meridians.Has clearing away heat and promoting production of body fluid, the effect of detumescence and apocenosis.Be used for clearing away heat-fire, detumescence and apocenosis disappears and pounces on the damage blood stasis.
Radix Bupleuri: be the dry root of umbelliferae bupleurum or Radix Bupeuri Scorzonerfolii..Cold nature, bitter in the mouth, suffering.Return liver, gallbladder meridian.The effect that having induces sweat brings down a fever.Be used for Antipyretic.
Squama Manis: be the scale of Manidae animal Manitis.Cold nature, salty in the mouth.Return liver, stomach warp.Effect with detumescence suppuration, loose silt collateral dredging, invigorating blood circulation analgesia.Be used for that the carbuncle skin ulcer is swollen, hemostasis, disease crust gather.
Semen Persicae: be the dry mature seed of rosaceous plant peach or Prunus davidiana.Property is put down, bitter in the mouth, sweet.GUIXIN, liver, large intestine channel.Effect with blood circulation promoting and blood stasis dispelling.Be used for traumatic injury, the congestion of dispelling swells and ache.
Olibanum: be the cured resin of Burseraceae aiphyllium.Warm in nature, acrid in the mouth, hardship.GUIXIN, liver, spleen channel.Has promoting blood circulation and stopping pain, the effect of detumescence and promoting granulation.
Myrrha: be the dry resin of olive subject plant Herba Violae tree or Ha Didingshu.Property is put down, bitter in the mouth, suffering.Return liver, spleen, the heart, kidney channel.Effect with promoting blood circulation and stopping pain, detumescence and promoting granulation.Joining Olibanum can promoting blood circulation to remove blood stasis, the circulation of qi promoting Shujin.
Sanguis Draxonis: be the resin in babassu Dracaena cambodiana and the trunk.Property is put down, sweet in the mouth, salty.GUIXIN, liver, spleen channel.Has promoting blood circulation to remove blood stasis, the effect of analgesic therapy.Be used for traumatic injury, swelling and pain due to blood stasis, hemostasia and promoting granulation.Join Myrrha, the power of its promoting blood circulation and breaking stagnation strengthens, and joins Olibanum, blood activating and promoting tissue regeneration, and sore is stretched muscle.
Radix Glycyrrhizae: be dicotyledon pulse family Radix Glycyrrhizae, Glycyrrhiza inflata Bat., or the root and rhizome of Glycyrrhiza glabra L..Property is put down, sweet in the mouth.Return spleen, stomach, lung meridian.Has the QI invigorating invigorating middle warmer, relieving spasm to stop pain, the effect of coordinating the actions of various ingredients in a prescription.
Medicine material consumption of the present invention is groped to sum up to draw through the inventor in a large number, and each raw material consumption is for all to have preferably curative effect in the following weight parts scope: Radix Angelicae Sinensis 7-17 part, Flos Carthami 7-17 part, Radix Trichosanthis 20-40 part, Radix Bupleuri 7-17 part, Squama Manis 7-17 part, Semen Persicae 7-17 part, Olibanum 7-17 part, Myrrha 7-17 part, Sanguis Draxonis 7-11 part, Radix Glycyrrhizae 2-4 part.
Wherein be preferably: 12 parts of Radix Angelicae Sinensis, 12 parts on Flos Carthami, 30 parts of Radix Trichosanthis, 12 parts of Radix Bupleuri, 12 parts of Squama Maniss, 12 parts in Semen Persicae, 12 parts of Olibanums, 12 parts of Myrrhas, 9 parts of Sanguis Draxonis, 3 parts in Radix Glycyrrhizae.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any conventional oral preparations, such as pill, powder, tablet, decoction etc.For example these crude drug pulverize mix homogeneously can be made that powder is taken after mixing it with water or directly decocting become decoction oral.
Medicine of the present invention has blood circulation promoting and blood stasis dispelling, channels sootheing and network vessel quickening, hemostasia and promoting granulation, the effects such as reducing swelling and alleviating pain, evident in efficacy, curative effect is fast, short treating period, and cost is low, simple to operate, according to clinical 200 routine patients are observed statistics, take medicine total effective rate course for the treatment of total effective rate 85%, two course for the treatment of 93% of the present invention.
The specific embodiment
Embodiment one, 7 parts of Radix Angelicae Sinensis, 7 parts on Flos Carthami, 20 parts of Radix Trichosanthis, 7 parts of Radix Bupleuri, 7 parts of Squama Maniss, 7 parts in Semen Persicae, 7 parts of Olibanums, 7 parts of Myrrhas, 7 parts of Sanguis Draxonis, 2 parts in Radix Glycyrrhizae.
Embodiment two, 12 parts of Radix Angelicae Sinensis, 12 parts on Flos Carthami, 30 parts of Radix Trichosanthis, 12 parts of Radix Bupleuri, 12 parts of Squama Maniss, 12 parts in Semen Persicae, 12 parts of Olibanums, 12 parts of Myrrhas, 9 parts of Sanguis Draxonis, 3 parts in Radix Glycyrrhizae.
Embodiment three, 17 parts of Radix Angelicae Sinensis, 17 parts on Flos Carthami, 40 parts of Radix Trichosanthis, 17 parts of Radix Bupleuri, 17 parts of Squama Maniss, 17 parts in Semen Persicae, 17 parts of Olibanums, 17 parts of Myrrhas, 11 parts of Sanguis Draxonis, 4 parts in Radix Glycyrrhizae.
The below is the clinical statistics data that the patient uses medicine of the present invention:
One, physical data
Accept out-patient's totally 200 examples for medical treatment, male's 144 examples wherein, women's 56 examples, M-F 2.6:1,24 years old mean age.
Two, tcm diagnosis standard
Swollen shape, twinge, localized pain are arranged outward, can livid purple ecchymosis or hematoma occur in the injury, joint motion is limited.Purplish tongue or ecchymosis is arranged, stringy and hesitant pulse.
Three, Therapeutic Method
According to drug weight proportioning weighting raw materials of the present invention (daily dose), decocting divides early, takes half an hour after meal for late twice, and 10 is a course for the treatment of.
Four, efficacy assessment standard
Criterion of therapeutical effect in " the new Chinese medicine guideline of clinical investigations " issued with reference to Ministry of Public Health is judged.
Cure: the sings and symptoms complete obiteration, functional rehabilitation is normal;
Produce effects: sings and symptoms is clearly better, and functional activity recovers substantially, can participate in normal operation;
Effectively: sings and symptoms improves, and functional activity is improved, and can participate in light work;
Invalid: sings and symptoms is without obvious improvement, and each side is all without improving.
Five, therapeutic outcome statistics
Wherein: total effective rate=cure rate+obvious effective rate+effective percentage
Model case and curative effect:
Case one, Wang, the woman 16 years old, sprains left ankle accidentally during high jump.Hindering walked lamely in rear 10 minutes examines, the left ankle outside, instep swelling 6cm * 9cm, and the skin ecchymosis, pain, tenderness, ankle moving is limited.Take medicine of the present invention after course for the treatment of, swelling, pain, tenderness are eliminated fully, and functional rehabilitation is normal.
Case two, Zhang, the man, 33 years old, first quarter moon front right sprain of ankle swelled and ache, tenderness, ecchymosis is arranged, walking disorder, x-ray shows: the part has no obvious fracture.Be diagnosed as right Lateral collateral ligament of ankle joint acute sprain.Take medicine of the present invention after course for the treatment of, recheck partial gall and disappear, can normally walk.
Case three, Chen, the man, 34 years old, the right knee joint of playing basketball was injured, and not too many uncomfortable at that time, knee has the swelling sense when examining, and right lower limb can not be had an effect, and is not painful.Be diagnosed as right anterior cruciate ligament of knee joint fracture, the medial and lateral meniscus injury of right knee joint, right knee joint-effusion, suggestion was lain up one month, as far as possible few movable, take simultaneously medicine of the present invention, after two courses for the treatment of, further consultation swelling disappears, and arthrogryposis can reach 90 °, can level walking.
Claims (2)
1. Chinese medicine composition for the treatment of traumatic injury, it is characterized in that, this Chinese medicine composition is the ingredients by following weight portion: Radix Angelicae Sinensis 7-17 part, Flos Carthami 7-17 part, Radix Trichosanthis 20-40 part, Radix Bupleuri 7-17 part, Squama Manis 7-17 part, Semen Persicae 7-17 part, Olibanum 7-17 part, Myrrha 7-17 part, Sanguis Draxonis 7-11 part, Radix Glycyrrhizae 2-4 part.
2. according to the Chinese medicine composition of claims 1 described treatment traumatic injury, it is characterized in that, by the ingredients of following weight portion: 12 parts of Radix Angelicae Sinensis, 12 parts on Flos Carthami, 30 parts of Radix Trichosanthis, 12 parts of Radix Bupleuri, 12 parts of Squama Maniss, 12 parts in Semen Persicae, 12 parts of Olibanums, 12 parts of Myrrhas, 9 parts of Sanguis Draxonis, 3 parts in Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104080237A CN102861197A (en) | 2012-10-24 | 2012-10-24 | Traditional Chinese medicine composition for treating injuries from falls, fractures, contusions and strains |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104080237A CN102861197A (en) | 2012-10-24 | 2012-10-24 | Traditional Chinese medicine composition for treating injuries from falls, fractures, contusions and strains |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102861197A true CN102861197A (en) | 2013-01-09 |
Family
ID=47440512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012104080237A Pending CN102861197A (en) | 2012-10-24 | 2012-10-24 | Traditional Chinese medicine composition for treating injuries from falls, fractures, contusions and strains |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102861197A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105311180A (en) * | 2014-07-30 | 2016-02-10 | 徐长春 | Formulation for treating traumatic injuries |
| CN106138571A (en) * | 2016-08-12 | 2016-11-23 | 丁韧 | A kind of preparation method of formula treating traumatic injury and combinations thereof thing |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1077121A (en) * | 1992-04-06 | 1993-10-13 | 朱思纯 | The manufacture method of capsule for curing spondylopathy |
| CN1457852A (en) * | 2003-05-14 | 2003-11-26 | 居小平 | Chinese medicine composition for curing traumatic injury and pains in chest and hypochondrium and its preparing method |
| CN102526288A (en) * | 2011-11-12 | 2012-07-04 | 李承平 | Chinese patent medicine for treating traumatic injury |
-
2012
- 2012-10-24 CN CN2012104080237A patent/CN102861197A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1077121A (en) * | 1992-04-06 | 1993-10-13 | 朱思纯 | The manufacture method of capsule for curing spondylopathy |
| CN1457852A (en) * | 2003-05-14 | 2003-11-26 | 居小平 | Chinese medicine composition for curing traumatic injury and pains in chest and hypochondrium and its preparing method |
| CN102526288A (en) * | 2011-11-12 | 2012-07-04 | 李承平 | Chinese patent medicine for treating traumatic injury |
Non-Patent Citations (2)
| Title |
|---|
| 陈庆平等: "名医印会河教授临床抓主症经验集粹(14)", 《中国乡村医药》, vol. 8, no. 10, 31 October 2001 (2001-10-31), pages 27 * |
| 魏荣友: "复元活血汤加味治疗外伤性胸胁痛", 《山东中医杂志》, vol. 17, no. 04, 20 April 1998 (1998-04-20), pages 160 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105311180A (en) * | 2014-07-30 | 2016-02-10 | 徐长春 | Formulation for treating traumatic injuries |
| CN106138571A (en) * | 2016-08-12 | 2016-11-23 | 丁韧 | A kind of preparation method of formula treating traumatic injury and combinations thereof thing |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102755537B (en) | External Chinese patent medicine for treating lumbocrural pains and application of external Chinese patent medicine | |
| CN102793883B (en) | Plaster for treating intervertebral disc protrusion and cervical spondylosis | |
| CN101890104A (en) | Chinese medicament for treating neck, shoulder, waist and leg pains | |
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN105616824A (en) | Bone reunion plaster and preparation method therefor | |
| CN102698085B (en) | Chinese medicinal plaster for treating arthritis | |
| CN101417003A (en) | Traditional Chinese medicine composition for treating vertebras disease | |
| CN102949646A (en) | Traditional Chinese medicine preparation for curing femoral head necrosis | |
| CN102872226A (en) | Traditional Chinese medicine composition for treating arthralgia | |
| CN102512560B (en) | Traditional Chinese medicinal composition for treating arthromyodynia | |
| CN104740142A (en) | Traditional Chinese medicine for treating sciatica | |
| CN102861197A (en) | Traditional Chinese medicine composition for treating injuries from falls, fractures, contusions and strains | |
| CN101690779B (en) | Traditional Chinese medicine for oral taking for treating scapulohumeral periarthritis | |
| CN106139015A (en) | A kind of Chinese medicine composition treating neck-shoulder pain, lumbago and leg pain | |
| CN102988833B (en) | Traditional Chinese medicine composition for treating rheumatism | |
| CN102430084A (en) | Traditional Chinese medicine composite for treating arthralgia-synadrome | |
| CN104258285A (en) | Medicine for treating lumbar bone hyperplasia through internal and external application and preparation method thereof | |
| CN104524080A (en) | Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method | |
| CN104367679A (en) | Traditional Chinese medicine composition ointment for treating rheumatism and bone diseases | |
| CN109908245A (en) | It is a kind of for treating the Chinese medicine composition of neck-shoulder pain, lumbago and leg pain disease | |
| CN102784212A (en) | Chinese medicine composition for treating arthralgia-synadrome | |
| CN100589819C (en) | Chinese medicine for oral administration for treating lumbar hyperosteogeny | |
| CN105194411A (en) | Formula of traditional Chinese medicine for treating scapulobumeral periarthritis | |
| CN102764363B (en) | Multifunctional external spray liniment | |
| CN103893606A (en) | Traditional Chinese medicine formula for treating scapulohumeral periarthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130109 |